China Equity Firm Says Co-founding Son Of Premier Left Company
This article was originally published in PharmAsia News
Executive Summary
A major Chinese investor in Sihuan Pharmaceutical Holdings Group denied the son of the nation's premier was still an executive with New Horizon Capital